文

献第 1 章〜特典

9-1

参考文献

（1）Ueshima H. Explanation for the Japanese paradox: prevention of increase in coronary
heart disease and reduction in stroke. J Atheroscler Thromb. 2007; 14: 278-86.
（2）Kubo M, 他, Trends in the incidence, mortality, and survival rate of cardiovascular disease
in a Japanese Community:the Hisayama study. Stroke. 2003; 34: 2349-54.
（3）介護保険事業状況報告 [Internet]. [cited 2018 Feb 26]. Available from: https://www.e-stat.
go.jp/stat-search/files?page=1&toukei=00450351&tstat=000001031648（4）国民生活基礎調査 [Internet]. [cited 2018 Feb 2]. Available from: https://www.e-stat.go.jp/
stat-search/files? page=1&toukei=00450061&tstat=000001031016（5）Yoshida D, Ninomiya T, Doi Y, Hata J, Fukuhara M, Ikeda F, Mukai N, Kiyohara Y.
Preva lence a nd ca u ses o f f u nc t io na l d isa bi l it y i n a n elder l y g enera l po pu la t io n o f
Japanese: the Hisayama study. J Epidemiol. 2012; 22: 222-9.
（6）Takashima N, Arima H, Kita Y, Fujii T, Miyamatsu N, Komori M, Sugimoto Y, Nagata S,
Miura K, Nozaki K. Incidence, ma nagement a nd short-term outcome of stroke in a
general population of 1.4 million Japanese- Shiga Stroke Registry. Circ J. 2017.
（7）K u c h a r s k a - N e w t o n A , G r i s w o l d M , Y a o Z H , F o r a k e r R , R o s e K , R o s a m o n d W ,Wagenknecht L, Koton S, Pompeii L, Windham BG. Cardiovascular Disease and Patternsof Change in Functional Status Over 15 Years: Findings From the Atherosclerosis Risk
in Communities (ARIC) Study. J Am Heart Assoc. 2017; 6.
（8）D h a m o o n M S , L o n g s t r e t h W T , J r . , Ba r t z T M , K a p l a n R C , E l k i n d M S V . D i s a b i l i t y
tra jectories bef ore and af ter stroke and myocardial infarction: The Cardiovascular
Health Study. JAMA Neurol. 2017; 74: 1439-45.
（9）Hozawa A, Okamura T, Murakami Y, Kadowaki T, Okuda N, Takashima N, Hayakawa T,
Kita Y, Miura K, Nakamura Y, Okayama A, Ueshima H, Group NDR. High blood pressurein middle age is associated with a future decline in activities of daily living. NIPPONDATA 80. J Hum Hypertens. 2009; 23: 546-52.
（10）Takashima N, Miura K, Hozawa A, Okamura T, Hayakawa T, Okuda N, Kadowaki T,
Murakami Y, Kita Y, Nakamura Y, Oka yama A, Ueshima H, Group NDR. Cigarettesmoking in middle age and a long-term risk of impaired activities of daily living: NIPPONDATA 80. Nicotine Tob Res. 2010; 12: 944-9.
（11）Hayakawa T, Okamura T, Okayama A, Kanda H, Watanabe M, Kita Y, Miura K, Ueshima H.
R e l a t i o n s h i p b e t w e e n 5- y e a r d e c l i n e i n i n s t r u m e n t a l a c t i v i t y o f d a i l y l i v i n g a n d
accumulation of cardiovascular risk factors: NIPPON DATA 90. J Atheroscler Thromb.
2010; 17: 64-72.
（12）日本老年医学会. フレイルに関する日本老年医学会からのステートメント 2014 [updated 2014 May;c i t e d 2018 F e b 10] . A v a i l a b l e f r o m : h t t p s : / / w w w . j p n - g e r i a t - s o c . o r . j p / i n f o / t o p i c s /pdf/20140513_01_01.pdf（13）Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R,
Kop WJ, Burke G, McBurnie MA, Cardiovascular Health Study Collaborative Research G.
Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56:
M146-56.
（14）Kojima G, Iliffe S, Taniguchi Y, Shimada H, Rakugi H, Walters K. Prevalence of frailty inJapan: A systematic review and meta-analysis. J Epidemiol. 2017; 27: 347-53.
（15）S a t a k e S , S h i m a d a H , Y a m a d a M , K i m H , Y o s h i d a H , G o n d o Y , M a t s u b a y a s h i K ,Matsushita E, Kuzuya M, Kozaki K, Sugimoto K, Senda K, Sakuma M, Endo N, Arai H.
Prevalence of frailty among community-dwellers and outpatients in Japan as defined by

9-2

the Japanese version of the Cardiovascular Health Study criteria. Geriatr Gerontol Int.
2017; 17: 2629-34.
（16）Makizako H, Shimada H, Doi T, Tsutsumimoto K, Suzuki T. Impact of physical frailty on

生活習慣病の疫学

第1章

disability in community-dwelling older adults: a prospective cohort study. BMJ Open.
2015; 5: e008462.
Y, Ninomiya T. Trends in dementia prevalence, incidence, and survival rate in a
Japanese community. Neurology. 2017; 88: 1925-32.
（18）Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, Ballard C,
Banerjee S, Burns A, Cohen-Mansfield J, Cooper C, Fox N, Gitlin LN, Howard R, Kales HC,
Larson EB, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbaek G, Teri
L, Mukadam N. Dementia prevention, intervention, and care. Lancet. 2017; 390: 2673-734.
（19）Fujiyoshi A, Ohkubo T, Miura K, Murakami Y, Nagasawa SY, Okamura T, Ueshima H.
Blood pressure categories and long-term risk of cardiovascular disease according to age（20）Takashima N, Ohkubo T, Miura K, Okamura T, Murakami Y, Fujiyoshi A, Nagasawa SY,
Kadota A, Kita Y, Miyagawa N, Hisamatsu T, Hayakawa T, Okayama A, Ueshima H.
Long -t erm risk of BP va lues a bove norma l f or ca rdiova scula r morta lit y: a 24-yea robservation of Japanese aged 30 to 92 years. J Hypertens. 2012; 30: 2299-306.
（21）Ikeda A, Iso H, Yamagishi K, Inoue M, Tsugane S. Blood pressure and the risk of stroke,
cardiovascular disease, and all-cause mortality among Japanese: the JPHC Study. Am J

第3章

保健指導プログラムの構成と実際

group in Japanese men and women. Hypertens Res. 2012; 35: 947-53.

第2章

保健指導の基礎知識（17）Ohara T, Hata J, Yoshida D, Mukai N, Nagata M, Iwaki T, Kitazono T, Kanba S, Kiyohara

Hypertens. 2009; 22: 273-80.
（22）Arima H, Tanizaki Y, Yonemoto K, Doi Y, Ninomiya T, Hata J, Fukuhara M, Matsumura K,
Hisayama study. J Hypertens. 2009; 27: 2437-43.
（23）Imano H, Kitamura A, Sato S, Kiyama M, Ohira T, Yamagishi K, Noda H, Tanigawa T, Iso
H, Shimamoto T. Trends for blood pressure and its contribution to stroke incidence int h e m idd le -a g ed Ja pa n ese po pu la t i o n : t h e Ci r c u la t o r y R i s k i n Co m m u n i t ies S t ud y
(CIRCS). Stroke. 2009; 40: 1571-7.

第4章

保健指導の技術

Iida M, Kiyohara Y. Impact of blood pressure levels on different types of stroke: the（24）Murakami Y, Hozawa A, Okamura T, Ueshima H. Relation of blood pressure and allcause mortality in 180,000 Japanese participants: pooled analysis of 13 cohort studies.
Hypertension. 2008; 51: 1483-91.
（25）Ikeda N, Saito E, Kondo N, Inoue M, Ikeda S, Satoh T, Wada K, Stickley A, Katanoda K,
What has made the population of Japan healthy? Lancet. 2011; 378: 1094-105.
（26）Turin TC, Murakami Y, Miura K, Rumana N, Kita Y, Hayakawa T, Okamura T, Okayama
A, Ueshima H. Hypertension and life expectancy among Japanese: NIPPON DATA80.

支援の場面

Mizoue T, Noda M, Iso H, Fujino Y, Sobue T, Tsugane S, Naghavi M, Ezzati M, Shibuya K.

第5章

Hypertens Res. 2012; 35: 954-8.
（27）厚生労働省. 平成28年国民健康・栄養調査報告; 2016.
（28）三浦克之（研究代表者）. 厚生労働行政推進調査事業費補助金・循環器疾患・糖尿病等生活習慣病対策

2003.

9-3



2019.
（29）Stamler J, Elliott P, Chan Q. INTERMAP appendix tables. J Hum Hypertens 17: 665-775,

生活習慣病予防の社会制度

NIPPON DATA80/90/2010/2020（H30−循環器等−指定−002）」
平成30年度総括・分担研究報告書

第6章

医療保険者の保健事業

総合研究事業「新旧（1980-2020年）ライフスタイルからみた国民代表集団大規模コホート研究：Health Education Manual（30）Nakamura K, Okamura T, Hayakawa T, Hozawa A, Kadowaki T, Murakami Y, et al.
The proportion of individuals with obesity-induced hypertension among total
hypertensives in a general Japanese population: NIPPON DATA80, 90. Eur J Epidemiol
2007; 22: 691-698.
（31）Neter JE, Stam BE, Kok EJ, et al. Influence of weight reduction on blood pressure: a metaanalysis of randomized controlled trials. Hypertension 42: 878-884, 2003.
（32）Marmot MG, Elliott P, Shipley MJ, Dyer AR, Ueshima H, Beevers DG, et al. Alcohol andblood pressure: the INTERSALT study. BMJ 1994; 308: 1263-1267.
（33）Yoshita K, Miura K, Morikawa Y, Ishizaki M, Kido T, Naruse Y, et al. Relationship ofalcohol consumption to 7 year blood pressure change in Japanese men. J Hypertens
2005;23:1485-1490.
（34）Okamura T, Tanaka T, Yoshita K, Chiga N, Takebayashi T, Kikuchi Y, et al. Specificalcoholic beverage and blood pressure in a middle-aged Japanese population: the Highrisk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) Study. J
Hum Hypertens 2004; 18: 9-16.
（35）Witteman JC, Willett WC, Stampfer MJ, Colditz GA, Kok FJ, Sacks FM, et al. Relation ofmodera te a lcohol consumpt ion a nd risk of systemic hypertension in women. Am J
Cardiol 1990; 65: 633-637.
（36）Tsuruta M, Adachi H, Hirai Y, Fujiura Y, Imaizumi T. Association between alcohol
intake and development of hypertension in Japanese normotensive men: 12-year followup study. Am J Hypertens 2000; 13(5 Pt 1):482-487.
（37）Ueshima H, Mikawa K, Baba S, Sasaki S, Ozawa H, Tsushima M, et al. Effect of reduced
alcohol consumption on blood pressure in untreated hypertensive men. Hypertension
1993; 21: 248-252.
（38）Xin X, He J, Frontini MG, Ogden LG, Motsama i OI, Whelton PK. Ef f ects of a lcohol
reduction on blood pressure: a meta-analysis of randomized controlled trials.
Hypertension 2001;38: 1112-1117.
（39）Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C,
DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P,
Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr,
Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/
ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, andma nagement of high blood pressure in adults: a report of the America n College of
Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Hypertension. 2018; 71(6): e13–e115.
（40）日本高血圧学会高血圧治療ガイドライン作成委員会編. 高血圧治療ガイドライン2019. 日本高血圧学会,
2019.
（41）Kiyonaga A, Arakawa K, Tanaka H, Shindo M. Blood pressure and hormonal responses
to aerobic exercise. Hypertension 1985; 7: 125-131.
（42）Welton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a metaanalysis of randomized controlled trials. Ann Intern Med 2002; 136: 493-503.
（43）Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review
and meta-analysis. J Am Heart Assoc. 2013; 2: e004473.
（44）Dahl LK. Possible role of salt intake in the development of essential hypertension, in
Cottier P, Bock KD (eds): Essential Hypertension – An International Symposium. Berlin,

9-4

Springer-Verlag, 1960, pp 53-65.
（45）Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte
e x c r e t i o n a n d b l o o d p r e s s u r e . R e s u l t s f o r 24 h o u r u r i n a r y s o d i u m a n d p o t a s s i u m

生活習慣病の疫学

第1章

excretion. BMJ 1988; 297: 319-328.
（46）C u t l e r J A , F o l l m a n n D , A l l e n d e r P S . R a n d o m i z e d t r i a l s o f s o d i u m r e d u c t i o n : a nanalysis of randomized trials. Implications for public health. J Hum Hypertens 2002; 16:761-770.
（48）Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns
on blood pressure. N Engl J Med 1997; 336:1117-1124.
（49）Miura K, Torii S. Diet, Nutrients, and the Prevention of Hypertension. Curr Nutr Rep
2012; DOI 10.1007/s13668-012-0012-4.
（50）UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control withcomplications in patients with type 2 diabetes (UKPDS33). Lancet 1998; 352: 837-53.
（51）The Diabetes Control and Complications Trial Research Group. The effect of intensive
treatment of diabetes on the development and progression of long-term complications ininsulin-dependent diabetes mellitus. N Engl J Med. 1993; 329: 977-86.
（52）Zhang X et al.; Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA
304: 649-56, 2010.

第3章

保健指導プログラムの構成と実際

sulphonylureas or insulin compared with conventional treatment and risk of

第2章

保健指導の基礎知識

overview. Am J Clin Nutr 1997; 65(suppl): 643S-651S.
（47）He F J, Ma cGreg or GA. Ef f ect of modest sa lt reduct ion on blood pressure: a meta -（53）K a w a s a k i R , e t a l . ; J a p a n D i a b e t e s C o m p l i c a t i o n s S t u d y G r o u p : I n c i d e n c e a n d
progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year
94, 2011.
（54）中江公裕，他：わが国における視覚障害の現状．厚生労働省難治性疾患克服研究事業 網脈絡膜・視神経萎縮症に関する研究：平成17年度研究報告書．263-267, 2006.
（55）一般社団法人日本透析医学会（http://www.jsdt.or.jp/）：図説 わが国の慢性透析療法の現況（56）日本糖尿病学会：糖尿病網膜症の治療．科学的根拠に基づく糖尿病診療ガイドライン2013.

第4章

保健指導の技術

follow-up study of the Japan Diabetes Complications Study (JDCS). Diabetologia. 54: 2288-（57）Yokoyama H, et al. Microalbuminuria is common in Japanese: Type 2 Diabetic Patients.
A nationwide survey from the Japan Diabetes Clinical Data Management Study Group(JDDM 10). Diabetes Care, 30: 989-92, 2007.
（58）Katayama S, et al. for the Japan Diabetes Complications Study Group. Low transitionindividuals: the Japan Diabetes Complications Study (JDCS). Diabetologia 54: 1025–31,
2011.
（59）Molitch ME, et al.; Diabetic nephropathy. American Diabetes Association. Diabetes

支援の場面

rate from normo- and low Microalbuminuria to proteinuria in Japanese type 2 diabetic

第5章

Care. 26 Suppl 1: S94-8, 2003.
（60）Ritz E, et al.; Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med. 341:
1127-33, 1999.



生活習慣病予防の社会制度

第6章

医療保険者の保健事業（61）日本糖尿病対策推進会議（http://www.med.or.jp/tounyoubyou/）：日本における糖尿病患者の足外観異常, および, 糖尿病性神経障害の実態に関する報告. 平成20年３月.
（62）The DECODE study group on behalf of the European Diabetes Epidemiology Group:
Glucose tolerance and mortality: comparison of WHO and American. Lancet; 354: 617–21,
1999.

9-5

Health Education Manual（63）The DECODE study group on behalf of the European Diabetes Epidemiology Group : Is
the Current Definition for Diabetes Relevant to Mortality Risk From All Causes andCardiovascular and Noncardiovascular Diseases? Diabetes Care 26: 688–696, 2003.
（64）JL Chiasson, et al. Acarbose f or prevention of type 2 dia betes mellitus: the STOPNIDDM randomised trial.Lancet. 359, 2072-2077, 2002.
（65）JL Chia sson, et a l. Acarbose trea t ment a nd t he risk of ca rdiova scula r disea se a nd
hypertension in pa t ient s wit h impa ired g lucose tolera nce: t he STOP-NIDDM tria l.
JAMA. 290, 486-494, 2003.
（66）Doi Y, et al. Impact of Glucose Tolerance Status on Development of Ischemic Stroke andCoronary Heart Disease in a General Japanese Population: The Hisayama Study. Stroke
2010; 41: 203-9.
（67）Kadowaki S, et al. Relationship of elevated casual blood glucose level with coronary
heart disease, cardiovascular disease and all-cause mortality in a representative sampleof the Japanese population. NIPPON DATA80. Diabetologia 2008; 51; 575-82.
（68）K o k u b o Y , e t a l . T h e c o m b i n e d i m p a c t o f b l o o d p r e s s u r e c a t e g o r y a n d g l u c o s eabnormality on the incidence of cardiovascular diseases in a Japanese urban cohort: theSuita Study. Hypertens Res 2010; 33: 1238-43.
（69）Watanabe M, et al. New diagnosis criteria for diabetes with hemoglobin A1c and risks ofmacro-vascular complications in an urban Japanese cohort: The Suita Study. Diabetes
Res Clin Pract 2010; 88: e20-3.
（70）Watanabe M, et al. Serum 1,5-anhydro-d-glucitol levels predict first-ever cardiovasculard i s e a s e : A n 11- y e a r p o p u l a t i o n - b a s e d C o h o r t s t u d y i n J a p a n , t h e S u i t a S t u d y .
Atherosclerosis 2011; 216: 477–83.
（71）Holman RR et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl
J Med 2008; 359: 1577-1589.
（72）Nathan DM, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes
I n t e r v e n t i o n s a n d C o m p l i c a t i o n s ( DC C T / E DI C ) S t u d y R e s ea r c h G r o u p. I n t e n s i v ediabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J
Med; 353: 2643-53, 2005.
（73）Whiting DR, et al.; IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for2011 and 2030. Diabetes Res Clin Pract 2011; 94: 311-21.
（74）International Diabetes Federation（ IDF：国際 糖 尿 病連 合 ）ウェブサイト（ http://www.idf.
org/）（75）厚生省保険医療局（http://www.mhlw.go.jp/）：平成9年糖尿病実態調査（平成11年4月）.
（76）厚生労働省健康局（http://www.mhlw.go.jp/）：平成14年度糖尿病実態調査報告（平成16年６月）.
（77）厚生労働省健康局（http://www.mhlw.go.jp/）：平成19年国民健康・栄養調査報告.
（78）厚生労働省健康局（http://www.mhlw.go.jp/）：平成24年国民健康・栄養調査報告.
（79）厚生労働省健康局（http://www.mhlw.go.jp/）：平成28年国民健康・栄養調査報告.
（80）Pa n XR , e t a l. E f f ec t s o f Di e t a n d E x e r c i se i n P r e v e n t i n g N I DDM i n Peo pl e W i t h
Impaired Glucose Tolerance. The Da Qing IGT and Diabetes Study. Diabetes care 20: 53744, 1997.
（81）Tuomilehto J, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among
subjects with impaired glucose tolerance, N Engl J Med.; 344: 1343-50. 2001.
（82）K n o w l e r W C , e t a l . R e d u c t i o n i n t h e i n c i d e n c e o f t y p e 2 d i a b e t e s w i t h l i f e s t y l eintervention or metformin, N Engl J Med.; 346: 393-403. 2002.

9-6

（83）Ramachadran A et al. The Indian Diabetes Prevention Programme shows that lifestylemodif ication and metf ormin prevent type 2 diabetes in Asian Indian subjects with
impaired glucose tolerance (IDPP-1), Diabetologia.; 49: 289-97. 2006.

生活習慣病の疫学

第1章（84）Saito T, et al. Lifestyle modification and preventionof type 2 diabetes in overweight
Japanese with Impaired fasting glucose levels A randomized controlled trial. Arch（86）JM. Chan, et al.: Obesity, fat distribution, and weight gain as risk factors for clinicaldiabetes in men. Diabetes care 17: 961-9, 1994.
（87）Colditz GA, et al.: Weight gain as a risk factor for clinical diabetes mellitus in women.
Ann Intern Med.; 122: 481-6, 1995.
（88）Carey VJ, et al.: Body Fat Distribution and Risk of Non-lnsulin-dependent Diabetes
Mellitus in Women. The Nurses' Health Study. Am J Epidemiol. 145: 614-9, 1997.
（89）Sone H, et al. Energy intake and obesity in Japanese patients with type 2 diabetes.
（90）Jeon CY, et al. Physical activity of moderate intensity and risk of type 2 diabetes: asystematic review Diabetes Care 30: 744-52, 2007.
（91）Okada K, et al.: Leisure-time physical activity at weekends a nd the risk of Type 2
diabetes mellitus in Japanese men: the Osaka Health Survey. Diabet Med 17: 53-58, 2000.
（92）Nakanishi N, et al.: Daily life activity and risk of developing impaired fasting glucose or
Type2 diabetes in middel-aged Japanese. Diabetologia 47: 1768-1775, 2004.

第3章

保健指導プログラムの構成と実際

Lancet. 17; 363 (9404): 248-9, 2004.

第2章

保健指導の基礎知識

Intern Med. 2011; 171 (15): 1352-1360.
（85）健康・栄養情報研究会：国民栄養の現状（平成14年厚生労働省国民栄養調査結果），第一出版.

（93）C a r l s s o n S , e t a l . A l c o h o l c o n s u m p t i o n a n d t y p e 2 d i a b e t e s : m e t a a n a l y s i s o fepidemiological studies indicatesa U-shaped relationship. Diabetologia 48: 1051-1054,（94）Koppes LL, et al. Bouter LM, Heine RJ. Moderate alcohol consumption lowers the risk oftype 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 28:719-25, 2005.
（95）Baliunas DO, et al. Alcohol as a risk factor for type 2 diabetes: A systematic review andmeta-analysis. Diabetes Care 32: 2123-32, 2009.

第4章

保健指導の技術

2005.

（96）Tsumura K, et al.: Daily alcohol consumption and the risk of Type 2 diabetes in Japanese
Men. The Osaka Health Survey. Diabetes care 22: 1432-1437, 1999.
（97）Watanabe M, et al. Alcohol consumption and the risk of diabetes by body mass index
levels in a cohort of 5636 Japanese. Diabetes Res Clin Pract.; 57: 191-7, 2002.
self-reported diabetes among middle-aged Japanese: a population-based prospective
study in the JPHC study cohort I. Diabet Med 22: 323-31, 2005.
（99）Nakanishi N, et al. Alcohol consumption and risk for development of impaired fasting

支援の場面（98）Waki K, et al. for the JPHC Study Group. Alcohol consumption and other risk factors for第5章

glucose or type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2003; 26: 48-54.
（100）Willi C. Active Smoking and the Risk of Type 2 Diabetes. A Systematic Review and Metaanalysis. JAMA. 2007; 298 (22): 2654-64.

cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese

9-7PLoS One. 2012; 7 (2): e17061.
（102）Oka mura T, Ta na ka H, Miya ma t su N, et a l. The rela t ionship bet ween ser um t ota l

生活習慣病予防の社会制度

irrespective of weight gain: the Japan Public Health Center-Based Prospective Study.

第6章

医療保険者の保健事業（101）O b a S , e t a l . S m o k i n g c e s s a t i o n i n c r e a s e s s h o r t - t e r m r i s k o f t y p e 2 d i a b e t e sHealth Education Manual

cohort. Atherosclerosis 190: 216-23, 2007.
（103）Cui R, Iso H, Toyoshima H, et al. Serum total cholesterol levels and risk of mortality
from stroke and coronary heart disease in Japanese: the JACC study. Atherosclerosis
194: 415-20, 2007.
（104）Okamura T, Kokubo Y, Watanabe M, et al. Low-density-lipoprotein cholesterol and nonhigh density lipoprotein cholesterol and the incidence of cardiovascular disease in an
urban Japanese cohort study: the Suita study. Atherosclerosis 203: 587-92, 2009.
（105）Imano H, et al. Low-density lipoprotein cholesterol and risk of coronary heart disease
among Japanese men and women: The Circulatory Risk in Communities Study (CIRCS).
Prev Med 52: 381-6, 2011.
（106）Nagasawa SY, Okamura T, Iso H, et al. Relation Between Serum Total Cholesterol
Level and Cardiovascular Disease Stratified by Sex and Age Group: A Pooled Analysisof 65 594 Individuals From 10 Cohort Studies in Japan. J Am Heart Assoc; 1: e001974,
2012.
（107）Kitamura A, Iso H, Naito Y, et al. High-density lipoprotein cholesterol and prematurecoronary heart disease in urban Japanese men. Circulation;89: 2533-9, 1994.
（108）Briel M, Ferreira-Gonzalez I, You JJ , et al. Association between change in high density
lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic
review and meta-regression analysis. BMJ 338: b92, 2009.
（109）The AIM-HIGH Investigators. Niacin in Patients with Low HDL Cholesterol Levels
Receiving Intensive Statin Therapy. New Engl J Med 2011; 365: 2255-2267.
（110）Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J,
Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR,
Brewer B; ILLUMINATE Investigators. Effects of torcetrapib in patients at high risk forcoronary events. N Engl J Med 2007; 357: 2109-22.
（111）Hirata T, Sugiyama D, Nagasawa SY, Murakami Y, Saitoh S, Okayama A, Iso H, Irie F,
Sairenchi T, Miyamoto Y, Yamada M, Ishikawa S, Miura K, Ueshima H, Okamura T. A
pooled analysis of the association of isolated low levels of high-density lipoproteincholesterol with cardiovascular mortality in Japan. Eur J Epidemiol 2017; 32: 547-557.
（112）Iso H, Naito Y, Sato S, et al. Serum triglycerides and risk of coronary heart disease
among Japanese men and women. Am J Epidemiol 153: 490-499, 2001.
（113）O k a m u r a T , K o k u b o Y , W a t a n a b e M , e t a l . T r i g l y c e r i d e s a n d n o n - h i g h - d e n s i t ylipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanesecohort: the Suita study. Atherosclerosis 209: 290-4, 2010.
（114）Tanaka T, Okamura T. Blood cholesterol level and risk of stroke incommunity-based orworksite cohort studies: a review of Japanese cohort studies in the past 20 years. Keio J
Med 61: 79-88, 2012.
（115）Imamura T, Doi Y, Arima H, et al. LDL cholesterol a nd the development of stroke
subtypes and coronary heart disease in a general Japanese population: the Hisayama
study. Stroke; 40: 382-8, 2009.
（116）Nakamura H, Arakawa K, Itakura H, et al. Primary prevention of cardiovascular disease
with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial.
Lancet; 368 (9542): 1155-63, 2006.
（117）Kushiro T, Mizuno K, Nakaya N, et al. Pravastatin for cardiovascular event primarypreven t io n i n pa t ien t s wit h mi ld-t o-modera t e h y pert en sio n i n t he Ma na g emen t o f

9-8

Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.
Hypertension 53: 135-41, 2009.
（118）Amarenco P, Bogousslavsky J, Callahan A 3rd, et al. High-dose atorvastatin after stroke

生活習慣病の疫学

第1章

or transient ischemic attack. N Engl J Med 355: 549-59, 2006.
（119）Hosomi N, Nagai Y, Kohriyama T, Ohtsuki T, Aoki S, Nezu T, Maruyama H, Sunami N,
Fukushima M, Mori E, Minematsu K, Uchiyama S, Shinohara Y, Yamaguchi T,
Matsumoto M; J-STARS Collaborators. The Japan Statin Treatment Against Recurrent
Stroke (J-STARS): A Multicenter,Randomized, Open-label, Parallel-group Study.
EBioMedicine 2015; 2: 1071-8.
（120）J a c o b s D , B l a c k b u r n H , H i g g i n s M , e t a l . R e p o r t o f t h e c o n f e r e n c e o n l o w b l o o dcholesterol: mortality associations. Circulation, 86: 1046-1060, 1992.
（121）Hirano K, Yamashita S, Nakajima N, et al. Genetic Cholesteryl Ester Transfer Protein
deficiency is extremely frequent in Omagari area of Japan. Marked
longevity. Arterioscler Thromb Vasc Biol 17: 1053-1059, 1997.
（122）Moriyama Y, Okamura T, Inazu A, et al.: A Low Prevalence of Coronary Heart Disease
among Subjects with Increased High-Density Lipoprotein Cholesterol Levels, Including
Those with Plasma Cholesteryl Ester Transfer Protein Deficiency. Prev Med 27: 659-667,
1998.
（123）Curb JD, Abbott RD, Rodriguez BL, et al. A prospective study of HDL cholesterol and第3章

保健指導プログラムの構成と実際

h y pera l pha l i po prot ei nemia ca u sed by CETP g ene m ut a t io n is n ot a ssoc ia t ed wit h

第2章

保健指導の基礎知識

Yokota C, Kitagawa K, Terayama Y, Takagi M, Ibayashi S, Nakamura M, Origasa H,

cholesteryl ester transfer protein gene mutations and the risk of coronary heart diseasein the elderly. J Lipid Res 2004; 45: 948-53.
Ishikawa S, Murakami Y, Miura K, Ueshima H, Okamura T. Association of extremely
high levels of high-density lipoprotein cholesterol with cardiovascular mortality in apooled analysis of nine cohort studies including 43,407 individuals: the EPOCH-JAPAN
study. J Clin Lipidol, 12: 674-684, 2018.
（125）Verschuren WM, Jacobs DR, Bloemberg BP, et al. Serum total cholesterol and long-term

第4章

保健指導の技術（124）Hirata A, Sugiyama D, Watanabe M, Tamakoshi A, Iso H, Kotani K, Kiyama M, Yamada M,

coronary heart disease mortality in different cultures. Twenty-five-year follow-up of theseven countries study. JAMA. 274: 131-136, 1995.
（126）関川暁, 上島弘嗣, Curb DJ, Kuller LH. 21世紀の国際間比較対照研究 ERA-JUMP予防循環器病における日本の挑戦, 世界への貢献. 医学のあゆみ207: 482-486, 2003.
dl/h28-houkoku.html）（128）国立健康・栄養研究所：国民健康・栄養の現状−平成29年厚生労働省国民健康・栄養調査報告より−.
第一出版株式会社, 2019.

支援の場面（127）厚生労働省. 平成28年国民健康・栄養調査報告（https://www.mhlw.go.jp/bunya/kenkou/eiyou/

第5章（129）Guo Z, Miura K, Turin TC, et al. Relationship of the polyunsaturated to saturated fatty
acid ra t io t o ca rdiova scula r risk f act ors a nd meta bolic syndrome in Ja pa nese: t he
INTERLIPID study. J Atheroscler Thromb. 17(8):777-84. 2010.



生活習慣病予防の社会制度

第6章

医療保険者の保健事業（130）岡村智教, 東山 綾, 宮松直美. 喫煙による低HDL血症. 脂質代謝異常−高脂血症・低脂血症−. 日本臨床（増刊号）
65: 663-667, 2007.
（131）Imamura H, et al.: Relationship of cigarette smoking with blood pressure, serum lipids
and lipoproteins in young Japanese women. Clin Exp Pharmacol Physiol 27: 364-369, 2000.
（132）Kuzuya M, et al.: Effect of smoking habit on age-related changes in serum lipids: A cross-9-9

Health Education Manual

sectional and longitudinal analysis in a large Japanese cohort. Atherosclerosis 185: 183190, 2006.
（133）Bernaards CM, et al.: In a prospective study in young people, associations betweenchanges in smoking behavior and risk factors for cardiovascular disease were complex.
J Clin Epidemiol 58: 1165-1171, 2005.
（134）Ma eda K, e t a l.: T h e e f f ec t s o f c es sa t i o n f r o m c i g a r et t e s m o k i n g o n t h e l i pid a n dlipoprotein profiles: a meta-analysis. Prev Med.37: 283-290, 2003.
（135）Moffatt RJ, et al.: Effects of the Transdermal Nicotine Patch on Normalization of HDL-C
and Its Subfractions. Prev Med.31: 148-152, 2000.
（136）岡村智教, 早川岳人, 門脇 崇, 天本健司, 喜多義邦, 岡山 明, 上島弘嗣．日本人の代表集団における飲酒量の変化に伴う循環器疾患死亡の相対リスク, 絶対リスク変化量の推計−NIPPON DATA−．日本ア
ルコール・薬物医学会雑誌 36: 586-595, 2001.
（137）岡村智教ほか：HDLコレステロールと歩行習慣の関連-歩数計を用いた検討. 動脈硬化 21: 585-589,
1994.
（138）Choudhury SR, et al. Alcohol intake and serum lipids in a Japanese population. Int J
Epidemiol 23: 940-7, 1994.
（139）Higashiyama A, et al. Association with serum gamma-glutamyltransferase levels andalcohol consumption on stroke and coronary artery disease: the Suita study. Stroke 42 (6):1764-7, 2011.
（140）Higashiyama A, et al. Alcohol consumption and cardiovascular disease incidence in men
with and without hypertension: the Suita study. Hypertens Res; 36 (1): 58-64, 2013.
（141）Naito M, Nakayama T, Okamura T, et al. Effect of a 4-year workplace-based physicalactivity intervention program on the blood lipid profiles of participating employees: The
hig h-risk a nd population strateg y f or occupa t iona l hea lt h promotion (HIPOP-OHP)
study. Atherosclerosis; 197 (2): 784-790, 2008.
（142）Subra ma nia n S, Cha it A. Hypertrig lyceridemia seconda ry to obesit y a nd dia betes.
Biochim Biophys Acta. 1821: 819-25. 2012.
（143）Aucott L, Gray D, Rothnie H, et al. Effects of lifestyle interventions and long-term weightloss on lipid outcomes - a systematic review. Obes Rev. 12: e412-25. 2011.
（144）Eslick GD, Howe PR, Smith C, et al. Benefits of fish oil supplementation in hyperlipidemia:
a systematic review and meta-analysis. Int J Cardiol. 136. 4-16. 2009.
（145）Iso H, Kobayashi M, Ishihara J, et al. Intake of fish and n3 fatty acids and risk of coronary
heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study
Cohort I. Circulation. 113. 195-202. 2006.
（146）Iso H, Sato S, Folsom AR, et al. Serum fatty acids and fish intake in rural Japanese, urban
Japanese, Japanese American and Caucasian American men. Int J Epidemiol. 18: 374-81.
1989.
（147）日本動脈硬化学会編：動脈硬化性疾患予防ガイドライン2017年版. 日本動脈硬化学会, 2017.
（148）厚生労働省「日本人の食事摂取基準策定検討会」
報告書（2015年度版）.http://www.mhlw.go.jp/stf/
shingi/0000041824.html（149）Dhingra R, Sullivan L, Jacques PF, et al. Soft drink consumption and risk of developing
cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in thecommunity. Circulation. 116: 480-8. 2007.
（150）Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA. 288:
2569-78. 2002.

9-10

（151）Ikehara S, Iso H, Toyoshima H, et al. Alcohol consumption and mortality from stroke andcoronary heart disease among Japanese men and women: the Japan collaborative cohort
study. Stroke. 39: 2936-42. 2008.

生活習慣病の疫学

第1章（152）Lieber CS. Alcoholic f atty liver: its pathogenesis and mechanism of progression to
inflammation and fibrosis. Alcohol. 34: 9-19. 2004.
association with blood lipid levels and effects in reducing cardiovascular and all-cause
mortality. J Atheroscler Thromb.18: 833-45. 2011.
（154）Kelley GA, Kelley KS, Tran ZV. Walking, lipids, and lipoproteins: a meta-analysis ofrandomized controlled trials. Prev Med. 38: 651-61. 2004.
（155）K e l l e y G A , K e l l e y K S . I m p a c t o f p r o g r e s s i v e r e s i s t a n c e t r a i n i n g o n l i p i d s a n dlipoproteins in adults: a meta-analysis of randomized controlled trials. Prev Med. 48: 9-19.
2009.
（156）Sigal RJ, Kenny GP, Boulé NG, et al. Effects of aerobic training, resistance training, or
69. 2007.
（157）Harada-Siba M, Arai H, Okumura T, Yokota K, Oikawa S, Nohara A, Okada T, Ohta T,
Bujo H, Watanabe M, Wakatsuki A, Yamashita S. Multicenter study to determine thediagnosis criteria of heterozygous familial hypercholesterolemia in Japan. J Atheroscler
Thromb. 2012; 19: 1019-26.
（158）Lv J, Chen W, Sun D, et al. Gender-specific association between tobacco smoking and第3章

保健指導プログラムの構成と実際

both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med. 147: 357-

第2章

保健指導の基礎知識（153）K o b a S , T a n a k a H , M a r u y a m a C , e t a l . P h y s i c a l a c t i v i t y i n t h e Ja pa n p o p u l a t i o n :central obesity among 0.5 million Chinese people: the China Kadoorie Biobank Study.
PLoS One. 2015 Apr 21; 10 (4): e0124586.
ルギー消費量, および自律神経活動へ及ぼす影響．糖尿病48：761-770, 2005.
（160）Ma r u ya ma K, Sa t o S, Oh ira T, et a l. The joi n t im pa c t o n bei ng o ver weig ht o f sel freported behaviours of eating quickly and eating until full: cross sectional survey. BMJ.
2008 Oct 21; 337: a2002.
（161）Ma Y, Bertone ER, Stanek EJ, et al. Association between Eating Patterns and Obesity in

第4章

保健指導の技術（159）永井, 坂根, 森谷ら．朝食欠食, マクロニュートリエントバランスが若年健常者の食後血糖値, 満腹感, エネ

a Free-living US Adult Population. Am J Epidemiol 2003; 158: 85-92.
（162）C a m p i o n E W , G l y n n R J , D e L a b r y L O . A s y m p t o m a t i c h y p e r u r i c e m i a . R i s k s a n dconsequences in the Normative Aging Study. Am J Med. 1987; 82 (3): 421-6.
（163）Richette P, Bardin T. Gout. Lancet. 2010; 375 (9711): 318-28.
hyperuricemia. A long-term population study. Am J Med. 1967; 42 (1): 27-37.
（165）Yü T, Gutman AB. Uric acid nephrolithiasis in gout. Predisposing factors. Ann Intern
Med. 1967; 67 (6): 1133-48.

支援の場面（164）H a l l A P , B a r r y P E , D a w b e r T R , M c N a m a r a P M . E p i d e m i o l o g y o f g o u t a n d

第5章（166）Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia
as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis. 2004; 44 (4):642-50.



生活習慣病予防の社会制度

第6章

医療保険者の保健事業（167）Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS. Uric acid andincident kidney disease in the community. J Am Soc Nephrol. 2008; 19 (6): 1204-11.
（168）Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy products andrela t ionshi p t o ser um levels of uric a cid: t he Third Na t iona l Hea lt h a nd Nut rit ion
Examination Survey. Arthritis Rheum. 2005; 52 (1): 283-9.

9-11

Health Education Manual（169）Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy andprotein intake, and the risk of gout in men. N Engl J Med. 2004; 350 (11): 1093-103.
（170）Choi JW, Ford ES, Gao X, Choi HK. Sugar-sweetened soft drinks, diet soft drinks, andserum uric acid level: the Third National Health and Nutrition Examination Survey.
Arthritis Rheum. 2008; 59 (1): 109-16.
（171）Choi HK, Curhan G. Sof t drinks, fructose consumption, and the risk of gout in men:prospective cohort study. BMJ. 2008; 336 (7639): 309-12.
（172）Choi HK, Curhan G. Beer, liquor, and wine consumption and serum uric acid level: theThird National Health and Nutrition Examination Survey. Arthritis Rheum. 2004; 51 (6):1023-9.
（173）Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk ofincident gout in men: a prospective study. Lancet. 2004; 363 (9417): 1277-81.
（174）Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T, Matsuzawa Y.
Ef fect of visceral fat accumulation on uric acid metabolism in male obese subjects:
visceral fat obesity is linked more closely to overproduction of uric acid thansubcutaneous fat obesity. Metabolism. 1998; 47 (8): 929-33.
（175）Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension,
diuretic use, and risk of gout in men: the health professionals follow-up study. Arch
Intern Med. 2005; 165 (7): 742-8.
（176）Sadakane A, Tsutsumi A, Gotoh T, Ishikawa S, Ojima T, Kario K, Nakamura Y, Kayaba K.
Dietary patterns and levels of blood pressure and serum lipids in a Japanese population.
J Epidemiol. 2008; 18 (2): 58-67.
（177）Petkevičienė J, Klumbienė J, Ramažauskienė V, Kriaučionienė V, Sakytė E, Grabauskas V.
Diet and dyslipidemias in a Lithuanian rural population aged 25-64: the CINDI survey.
Medicina (Kaunas). 2012; 48 (4): 211-7.
（178）Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, D'Agostino RB, Gaziano
JM, Vasan RS. Sof t drink consumption and risk of developing cardiometabolic risk
factors and the metabolic syndrome in middle-aged adults in the community.
Circulation. 2007; 116 (5): 480-8.
（179）W a k a b a y a s h i I . C r o s s - s e c t i o n a l r e l a t i o n s h i p b e t w e e n a l c o h o l c o n s u m p t i o n a n dprevalence of metabolic syndrome in Japanese men and women. J Atheroscler Thromb.
2010; 17 (7): 695-704.
（180）Oka R, Miura K, Sakurai M, Nakamura K, Yagi K, Miyamoto S, Moriuchi T, Mabuchi H,
Koizumi J, Nomura H, Ta keda Y, Ina zu A, Noha ra A, Ka wa shiri MA, Na g a sa wa S,
Kobayashi J, Yamagishi M. Impacts of visceral adipose tissue and subcutaneous adipose
tissue on metabolic risk factors in middle-aged Japanese. Obesity (Silver Spring). 2010; 18(1): 153-60.
（181）Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patientswith gout: the Third National Health and Nutrition Examination Survey. Arthritis
Rheum. 2007; 57 (1): 109-15.
（182）疋田美穂. 高尿酸血症と生活習慣病, 糖代謝異常の関連に関する研究. 痛風と核酸代謝. 2000; 24 (2): 13951.
（183）厚生労働省. 国民健康・栄養調査. http://www.mhlw.go.jp/bunya/kenkou/kenkou_eiyou_
chousa.html（アクセス2019年２月19日）（184）Za varoni I, Mazza S, Fa nt uzzi M, Dall'Ag lio E, Bonora E, Delsig nore R, Passeri M,

9-12

Rea ven GM. Cha ng es i n i n s u l i n a nd l i pid met a bo l ism i n ma les w i t h a s y m pt oma t ic
hyperuricaemia. J Intern Med. 1993; 234 (1): 25-30.
（185）Z a v a r o n i I , B o n i n i L , F a n t u z z i M , D a l l ' A g l i o E , P a s s e r i M , R e a v e n G M .

生活習慣病の疫学

第1章

Hyperinsulinaemia, obesity, and syndrome X. J Intern Med. 1994; 235 (1): 51-6.
（186）Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC,

Heart Association; World Heart Federation; International Atherosclerosis Society;
International Association for the Study of Obesity. Harmonizing the metabolic
syndrome: a joint interim statement of the International Diabetes Federation Task
Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute;
American Heart Association; World Heart Federation; International Atherosclerosis
Society; and International Association for the Study of Obesity. Circulation. 2009; 120(16): 1640-5.
会雑誌. 2005; 94 (4): 794-809.
（188）日本痛風・核酸代謝学会ガイドライン改訂委員会. 高尿酸血症・痛風の治療ガイドライン
（第２版）
. 大阪,
メディカルレビュー社. 2010.
（189）Benedict JD, Forsham PH, Stetten D Jr. The metabolism of uric acid in the normal andgouty human studied with the aid of isotopic uric acid. J Biol Chem. 1949; 181 (1): 183-93.
（190）Scott JT, Holloway VP, Glass HI, Arnot RN. Studies of uric acid pool size and turnover

第3章

保健指導プログラムの構成と実際（187）メタボリックシンドローム診断基準検討委員会. メタボリックシンドロームの定義と診断基準. 日本内科学第2章

保健指導の基礎知識

James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on
Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American

rate. Ann Rheum Dis. 1969; 28 (4): 366-73.
（191）Ryu S, Chang Y, Zhang Y, Kim SG, Cho J, Son HJ, Shin H, Guallar E. A cohort study of（192）Nakamura K, Sakura i M, Miura K, Morikawa Y, Nagasawa SY, Ishizaki M, Kido T,
Naruse Y, Nakashima M, Nogawa K, Suwazono Y, Nakagawa H. HOMA-IR and the risk ofhyperuricemia: a prospective study in non-diabetic Japanese men. Diabetes Res Clin
Pract. 2014; 106 (1): 154-60.
（193）Leyva F, Wingrove CS, Godsland IF, Stevenson JC. The glycolytic pathway to coronary

第4章

保健指導の技術

hyperuricemia in middle-aged South Korean men. Am J Epidemiol. 2012; 175 (2): 133-43.

heart disease: a hypothesis. Metabolism. 1998; 47 (6): 657-62.
（194）Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance toinsulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acidconcentration. JAMA. 1991; 266 (21): 3008-11.
Effect of insulin on uric acid excretion in humans. Am J Physiol. 1995; 268 (1 Pt 1): E1-5.
（196）Hakoda M, Masunari N, Yamada M, Fujiwara S, Suzuki G, Kodama K, Kasagi F. Serum
uric acid concentration as a risk factor for cardiovascular mortality: a longterm cohort

支援の場面（195）Quiñones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, Ferrannini E.

第5章

study of atomic bomb survivors. J Rheumatol. 2005; 32 (5): 906-12.
（197）Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I
epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination(4): 243-51.

9-13



W; Gubbio Study Research Group. Serum uric acid for short-term prediction ofcardiovascular disease incidence in the Gubbio population Study. Acta Cardiol. 2001; 56

生活習慣病予防の社会制度（198）Puddu PE, Lanti M, Menotti A, Mancini M, Zanchetti A, Cirillo M, Angeletti M, Panarelli

第6章

医療保険者の保健事業

Survey. JAMA. 2000; 283 (18): 2404-10.

Health Education Manual（199）Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM. Uric acid is a risk factor
for myocardial infarction and stroke: the Rotterdam study. Stroke. 2006;37(6):1503-7.
（200）Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, Diem G, Pfeiffer K, Ulmer
H; VHM&PP St udy Group. Serum uric acid a nd risk of cardiova scular morta lit y: aprospective long-term study of 83,683 Austrian men. Clin Chem. 2008; 54 (2): 273-84.
（201）Strasak AM, Kelleher CC, Brant LJ, Rapp K, Ruttmann E, Concin H, Diem G, Pfeiffer KP,
Ulmer H; VHM&PP Study Group. Serum uric acid is an independent predictor for all
major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year followup study. Int J Cardiol. 2008; 125 (2): 232-9.
（202）Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. Hyperuricemia as a risk factor on
cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort
Study. Atherosclerosis. 2005; 183 (1): 147-55.
（203）C u l l e t o n B F , L a r s o n M G , K a n n e l W B , L e v y D . S e r u m u r i c a c i d a n d r i s k f o r
cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;
131 (1): 7-13.
（204）Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary
heart disease events. Heart. 1997; 78 (2): 147-53.
（205）Jee SH, Lee SY, Kim MT. Serum uric acid and risk of death from cancer, cardiovasculardisease or all causes in men. Eur J Cardiovasc Prev Rehabil. 2004; 11 (3): 185-91.
（206）Sakata K, Hashimoto T, Ueshima H, Okayama A; NIPPON DATA 80 Research Group.
Absence of an association between serum uric acid and mortality from cardiovasculardisease: NIPPON DATA 80, 1980-1994. National Integrated Pro jects f or Prospective
Observation of Non-communicable Diseases and its Trend in the Aged. Eur J Epidemiol.
2001; 17 (5): 461-8.
（207）箱田雅之. 血清尿酸値と心血管リスク. 痛風と核酸代謝. 2008; 32 (1): 1-12.
（208）Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia andcoronary heart disease: a systematic review and meta-analysis. Arthritis Care Res(Hoboken). 2010; 62 (2): 170-80.
（209）Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia andrisk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009; 61 (7): 88592.
（210）冨田眞佐子, 横田和彦, 水野正一. 健康診断，人間ドックにおける尿酸測定の意義. 高尿酸血症と痛風.
2010; 18 (1): 67-71.
（211）Yu TS, Berger L, Gutman AB. Renal function in gout. II. Effect of uric acid loading on
renal excretion of uric acid. Am J Med. 1962; 33: 829-44.
（212）Yamamoto T, Moriwaki Y, Takahashi S, Yamakita J, Tsutsumi Z, Ohata H, Hiroishi K,
Nakano T, Higashino K. Effect of ethanol and fructose on plasma uridine and purinebases. Metabolism. 1997; 46 (5): 544-7.
（213）Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Yamakita J, Higashino K. Effects offructose and xylitol on the urinary excretion of adenosine, uridine, and purine bases.
Metabolism. 1999; 48 (4): 520-4.
（214）Villegas R, Xiang YB, Elasy T, Xu WH, Cai H, Cai Q, Linton MF, Fazio S, Zheng W, Shu
XO. Purine-rich foods, protein intake, and the prevalence of hyperuricemia: the Shanghai
Men's Health Study. Nutr Metab Cardiovasc Dis. 2012; 22 (5): 409-16.
（215）Gao X, Qi L, Qiao N, Choi HK, Curhan G, Tucker KL, Ascherio A. Intake of added sugar

9-14and sugar-sweetened drink and serum uric acid concentration in US men and women.
Hypertension. 2007; 50 (2): 306-12.
（216）Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, D'Agostino RB, Gaziano

生活習慣病の疫学

第1章

JM, Vasan RS. Sof t drink consumption and risk of developing cardiometabolic risk
factors and the metabolic syndrome in middle-aged adults in the community.

Ma r t í n ez -G o n zá lez MA. Pred ic t or s o f weig h t g a i n i n a Med i t er ra n ea n c o h or t : t he
Seguimiento Universidad de Navarra Study 1. Am J Clin Nutr. 2006; 83 (2): 362-70.
（218）Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Yamakita J, Nakano T, Higashino K.
Ef fect of glucose on the plasma concentration and urinary excretion of uridine andpurine bases. Metabolism. 1999; 48 (3): 338-41.
（219）Kilinenberg JR, Goldfinger SE, Seegmiller JE. The effectiveness of the xanthine oxidase
inhibitor allopurinol in the treatment of gout. Ann Intern Med. 1965; 62: 639-47.
risk factors for uric acid stone formation. Eur J Nutr. 2003; 42 (6): 332-7.
（221）Zhou BF, Stamler J, Dennis B, Moag-Stahlberg A, Okuda N, Robertson C, Zhao L, Chan Q,
Elliott P; INTERMAP Research Group. Nutrient intakes of middle-aged men and womenin China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP
study. J Hum Hypertens. 2003; 17 (9): 623-30.
（222）国税庁. 酒税

お酒に関する情報

酒税課税関係統計資料. http://www.nta.go.jp/shiraberu/

第3章

保健指導プログラムの構成と実際（220）Siener R, Hesse A. The effect of a vegetarian and different omnivorous diets on urinary

第2章

保健指導の基礎知識

Circulation. 2007; 116 (5): 480-8.
（217）Be s - R a s t r o l l o M , S á n c h e z - V i l l e g a s A , G ó m e z - G r a c i a E , M a r t í n e z JA , P a ja r e s R M ,senmonjoho/sake/tokei/mokuji.htm（アクセス2013年2月22日）（223）Kaneko K, Yamanobe T, Fujimori S. Determination of purine contents of alcoholic
23 (8): 858-64.
（224）Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Ka T, Fukuchi M, Hada T. Effect ofbeer on the plasma concentrations of uridine and purine bases. Metabolism. 2002; 51 (10):1317-23.
（225）Yamamoto T, Moriwaki Y, Ka T, Inokuchi T, Takahashi S, Tsutsumi Z, Fukuchi M, Hada T.

第4章

保健指導の技術

beverages using high performance liquid chromatography. Biomed Chromatogr. 2009;

Ef fect of purine-f ree low-malt liquor (happo-shu) on the plasma concentrations andurinary excretion of purine bases and uridine--comparison between purine-free andregular happo-shu. Horm Metab Res. 2004; 36 (4): 231-7.
（226）Nishimura T, Shimizu T, Mineo I, Kawachi M, Ono A, Nakajima H, Kuwajima M, Kono N,
Metabolism. 1994; 43 (6): 745-8.
（227）清水孝郎, 西村隆通, 大野昭. 日常飲酒量が飲酒後の高尿酸血症に及ぼす影響. プリン・ピリミジン代謝.
1992; 16 (1): 9-13.

支援の場面

Matsuzawa Y. Influence of daily drinking habits on ethanol-induced hyperuricemia.

第5章（228）Yamanaka H, Kamatani N, Hakoda M, Terai C, Kawaguchi R, Kashiwazaki S. Analysis of
the genotypes for aldehyde dehydrogenase 2 in Japanese patients with primary gout.
Adv Exp Med Biol. 1994; 370: 53-6.

Suwazono Y, Nakagawa H. Alcohol intake and the risk of hyperuricaemia: a 6-year

9-15



1598-602.
（230）Nakamura K, Sakurai M, Miura K, Morikawa Y, Yoshita K, Ishizaki M, Kido T, Naruse Y,

生活習慣病予防の社会制度

production by activation of adenine nucleotide turnover. N Engl J Med. 1982; 307 (26):第6章

医療保険者の保健事業（229）F a l l e r J , F o x I H . E t h a n o l - i n d u c e d h y p e r u r i c e m i a : e v i d e n c e f o r i n c r e a s e d u r a t e

Health Education Manual

prospective study in Japanese men. Nutr Metab Cardiovasc Dis. 2012; 22 (11): 989-96.
（231）Yamashita S, Matsuzawa Y, Tokunaga K, Fujioka S, Tarui S. Studies on the impaired
metabolism of uric acid in obese subjects: marked reduction of renal urate excretion andits improvement by a low-calorie diet. Int J Obes. 1986; 10 (4): 255-64.
（232）Stewart KJ, Bacher AC, Turner K, Lim JG, Hees PS, Shapiro EP, Tayback M, Ouyang P.
Exercise and risk factors associated with metabolic syndrome in older adults. Am J Prev
Med. 2005 Jan; 28 (1): 9-18.
（233）Katzel LI, Bleecker ER, Rogus EM, Goldberg AP. Sequential effects of aerobic exercise
training and weight loss on risk factors for coronary disease in healthy, obese middleaged and older men. Metabolism. 1997; 46 (12): 1441-7.
（234）Yamanaka H, Kawagoe Y, Taniguchi A, Kaneko N, Kimata S, Hosoda S, Kamatani N,
Kashiwazaki S. Accelerated purine nucleotide degradation by anaerobic but not by
aerobic ergometer muscle exercise. Metabolism. 1992; 41 (4): 364-9.
（235）Kaya M, Moriwaki Y, Ka T, Inokuchi T, Yamamoto A, Takahashi S, Tsutsumi Z, Tsuzita J,
Oku Y, Yamamoto T. Plasma concentrations and urinary excretion of purine bases (uricacid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise. Metabolism.
2006; 55 (1): 103-7.
（236）伊藤朗, 三上俊夫, 丹信介. 各種運動時の血清尿酸値の動態. 尿酸. 1984; 8 (1): 38-47.
（237）Ka T, Yamamoto T, Moriwaki Y, Kaya M, Tsujita J, Takahashi S, Tsutsumi Z, Fukuchi M,
Hada T. Effect of exercise and beer on the plasma concentration and urinary excretion ofpurine bases. J Rheumatol. 2003; 30 (5): 1036-42.
（238）Ohno M, Ka T, Inokuchi T, Moriwaki Y, Yamamoto A, Takahashi S, Tsutsumi Z, Tsuzita J,
Yamamoto T, Nishiguchi S. Effects of exercise and grape juice ingestion in combination
on plasma concentrations of purine bases and uridine. Clin Chim Acta. 2008; 388 (1-2): 16772.
（239）Seegmiller JE, Rosenbloom FM, Kelley WN. Enzyme defect associated with a sexlinked human neurological disorder and excessive purine synthesis. Science. 1967; 155(3770): 1682-4.
（240）Kelley WN, Rosenbloom FM, Henderson JF, Seegmiller JE. A specific enzyme defect ingout associated with overproduction of uric acid. Proc Natl Acad Sci U S A. 1967; 57 (6):1735-9.
（241）P u i g J G , M i r a n d a M E , M a t e o s F A , P i c a z o M L , J i m é n e z M L , C a l v i n T S , G i l A A .
Hereditary nephropathy associated with hyperuricemia and gout. Arch Intern Med.
1993; 153 (3): 357-65.
（242）Pencina MJ, et al. Circulation 2009; 119: 3078-3084.
（243）NIPPON DATA80 Research Group. Circ J 2006; 70: 1249-1255.
（244）上島弘嗣編著,「NIPPON DATAからみた循環器疾患のエビデンス」, 日本医事新報社.
（245）Nishimura K, Okamura T, Watanabe M, et al. Predicting coronary heart disease usingr i s k f a c t o r c a t e g o r i e s f o r a Ja pa n e s e u r b a n p o p u l a t i o n , a n d c o m pa r i s o n w i t h t h eframingham risk score: the suita study. J Atheroscler Thromb. 2014;21(8):784-98.
（246）The Fifth Joint Task Force of the European Society of Cardiology and Other Societies
on Cardiovascular Disease Prevention in Clinical Practice. European Heart Journal 2012;
33: 1635–1701.
（247）Arima H, et al. Hypertens Res 2009; 32: 1119-1122.
（248）Ishikawa S, et al.; Jichi Medical School (JMS) Cohort Study Group. J Epidemiol. 2009; 19:9-16

101-106.
（249）Matsumoto M, et al.; Jichi Medical School (JMS) Cohort Study Group. J Epidemiol. 2009;
19: 94-100.

生活習慣病の疫学

第1章（250）Tanabe N, et al.; The Japan Arteriosclerosis Longitudinal Study Group. Circ J. 2010; 74:1346-1356.

第2章

保健指導の基礎知識（251）Kokubo Y, et al. Hypertens Res 2008; 31: 2027-2035.
（252）Alberti KGMM, et al. Circulation 2009; 120: 1640-1645.
（253）メタボリックシンドローム診断基準検討委員会 日本内科学会雑誌2005；94: 749.
（254）Barker DJ, et al. Diabetologia 1993; 36: 62-67.
（255）Curhan GC, et al. Circulation 1996; 94: 3246-3250.
（256）Miura K, et al. Am J Epidemiol 2001; 153: 783–789.
（257）Nanri A, et al. J Epidemiol Community Health 2011; 65: 1104-1110.
（258）Chou WT, et al. Circ J 2012, 2013; 77: 679-686.
（259）Go, A.S., et al., Chronic kidney disease and the risks of death, cardiovascular events, and（260）Levey, A.S., et al., The definition, classification, and prognosis of chronic kidney disease: a
KDIGO Controversies Conference report. Kidney Int, 2011. 80(1): p. 17-28.
（261）N a g a i , K ., e t a l ., R e l a t i o n s h i p be t w e e n E s t i m a t ed G l o m e r u l a r F i l t r a t i o n R a t e a n d
Cardiovascular Mortality in a Japanese Cohort with Long-Term Follow-Up. PLoS One,2016. 11(6): p. e0156792.
（262）わが国の慢性透析療法の現況（2016年12月31日現在）. 2018, 日本透析医学会統計調査委員会.

第3章

保健指導プログラムの構成と実際

hospitalization. N Engl J Med, 2004. 351(13): p. 1296-305.

（263）Pugliese, G., Updating the natural history of diabetic nephropathy. Acta Diabetol, 2014.
51(6): p. 905-15.
Handbook of nutrition and the kidney, W.E. Mitch and T.A. Ikizler, Editors. 2010, Wolter
Kluwer: Philadelphia. p. 50-57.
（265）厚生労働省. 人口動態調査 2017 [Available from: https://www.e-stat.go.jp/stat-search/files?page=1&query=%E4%BA%BA%E5%8F%A3%E5%8B%95%E6%85%8B%E8%AA%BF%E6%9F%BB&layout=dataset&lid=000001101884] accessed March 13 2018.

第4章

保健指導の技術（264）Bhan, I. and R. Thadhani, Calsium, phosphorus, and vitamin D in kidney disease, in（266）Sasaki N. The Relationship of Salt Intake to Hypertension in the Japanese. Geriatrics
1964; 19: 735-44. [published Online First: 1964/10/01]（267）厚生労働省. 平成28年国民健康・栄養調査報告 2017 [Available from: http://www.mhlw.go.jp/
bunya/kenkou/eiyou/h28-houkoku.html] accessed March 9 2018.

pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ
2013;346:f1325. doi: 10.1136/bmj.f1325 [published Online First: 2013/04/06]

支援の場面（268）奥田奈賀子 岡山明. ナトリウム・カリウム摂取と循環器疾患. 循環器内科 2011; 70 (6): 546-54.
（269）He F J, L i J, Ma c g r eg o r GA. E f f ec t o f l o n g er t er m m od e s t sa l t r ed u c t i o n o n bl o od

第5章（270）Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on
cardiovascular disease outcomes: observational follow-up of the trials of hypertension
prevention (TOHP). BMJ 2007; 334 (7599): 885-8. doi: 10.1136/bmj.39147.604896.55 [published346: f1378. doi: 10.1136/bmj.f1378 [published Online First: 2013/04/06]（272）Jackson SL, Cog swell ME, Zhao L, et a l. Association Between Urinary Sodium a nd

9-17



cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ 2013;

生活習慣病予防の社会制度（271）A b u r t o N J, Ha n s o n S , G u t i e r r e z H, e t a l . E f f ec t o f i n c r ea s ed po t a s s i u m i n t a k e o n

第6章

医療保険者の保健事業

Online First: 2007/04/24]

Health Education Manual

Potassium Excretion and Blood Pressure Among Adults in the United States: National
Health a nd Nutrition Examination Survey, 2014. Circulation 2018; 137 (3): 237-46. doi:
10.1161/CIRCULATIONAHA.117.029193.
（273）Okayama A, Okuda N, Miura K, et al. Dietary sodium-to-potassium ratio as a risk factor
for stroke, cardiovascular disease and all-cause mortality in Japan: the NIPPON DATA
80 cohort study. BMJ open 2016; 6 (7): e011632. doi: 10.1136/bmjopen-2016-011632.
（274）Chang HY, Hu YW, Yue CS, et al. Effect of potassium-enriched salt on cardiovascularm o r t a l i t y a n d m ed i c a l e x pe n s e s o f e l d e r l y m e n . T h e A m e r i c a n jo u r n a l o f c l i n i c a lnutrition 2006; 83 (6): 1289-96. [published Online First: 2006/06/10]（275）Harvard Report on Ca ncer Prevention. Volume 1: Ca uses of huma n ca ncer. Ca ncer
causes & control: CCC. 1996;7 Suppl 1:S3-59.
（276）Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence.
Cancer science. 2005; 96 (1):1-6.
（277）塚本徹哉, 立松正衞. 基礎医学から 高食塩食とピロリ菌による発癌. 日本医事新報 . 2005 (4252): 11-13.
（278）国立がん研究センターがん対策情報センター. がん登録・統計グラフデータベース. 2018; http://gdb.
ganjoho.jp/graph_db/index. Accessed March 13, 2018.
（279）Shikata K, Kiyohara Y, Kubo M, et al. A prospective study of dietary salt intake andgastric cancer incidence in a defined Japanese population: the Hisayama study.
International journal of cancer Journal international du cancer. 2006; 119 (1): 196-201.
（280）黒川清. 食塩と高血圧. 日病態栄養会誌 2001; 5 (1-6): 18.
（281）奥田奈賀子 上島弘嗣. 海外における食塩摂取量の推移と現状―24時間尿を用いた推定食塩摂取量より―.
カレントテラピー 2013; 31 (10): 14-19.
（282）He FJ, Brinsden HC, MacGregor GA. Salt reduction in the United Kingdom: a successful
experiment in public hea lt h. Journa l of huma n hypertension 2014; 28 (6): 345-52. doi:
10.1038/jhh.2013.105.
（283）Bernstein AM, Willett WC. Trends in 24-h urinary sodium excretion in the United States,
1957-2003: a systematic review. The American journal of clinical nutrition 2010; 92 (5): 117280. doi: 10.3945/ajcn.2010.29367 [published Online First: 2010/09/10]（284）Sasaki N. The Relationship of Salt Intake to Hypertension in the Japanese. Geriatrics
1964; 19: 735-44. [published Online First: 1964/10/01]（285）Uechi K, Sugimoto M, Kobayashi S, et al. Urine 24-Hour Sodium Excretion Decreasedb e t w e e n 1953 a n d 2014 i n J a p a n , b u t E s t i m a t e d I n t a k e S t i l l E x c e e d s t h e W H O
Recommendation. The Journal of nutrition 2017; 147 (3): 390-97. doi: 10.3945/jn.116.240960.
（286）Group ICR. Intersalt: an international study of electrolyte excretion and blood pressure.
Results f or 24 hour urinary sodium and potassium excretion. Intersalt Cooperative
Research Group. BMJ 1988; 297 (6644): 319-28. [published Online First: 1988/07/30]（287）Zhou BF, Stamler J, Dennis B, et al. Nutrient intakes of middle-aged men and women in
China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAPs t u d y . J o u r n a l o f h u m a n h y pe r t e n s i o n 2003; 17 (9) : 623-30. d o i : 10.1038/ s j. j h h .1001605[published Online First: 2003/09/19]（288）Dauchet L, Amouyel P, Hercberg S, Dallongeville J. Fruit and vegetable consumption
and risk of coronary heart disease: a meta-analysis of cohort studies. The Journal ofnutrition. 2006; 136 (10): 2588-2593.
（289）Okuda N, Miura K, Okayama A, et al. Fruit and vegetable intake and mortality fromcardiovascular disease in Japan: a 24-year follow-up of the NIPPON DATA80 Study.

9-18

European journal of clinical nutrition. 2015; 69 (4): 482-488.
（290）厚生労働省. 平成28年国民健康・栄養調査報告. 2017; http://www.mhlw.go.jp/bunya/kenkou/
eiyou/h28-houkoku.html. Accessed March 9, 2018.

生活習慣病の疫学

第1章（291）Institute NC. Usual Dietary Intakes: Food Intakes, US Population, 2001-04. Risk Factor
Monitoring and Methods Branch Web site. Applied Research Program. https://epi.

http://www.nibiohn.go.jp/eiken/chosa/kokumin_eiyou/doc_year/1947/1947_kek.pdf ]accessed March 1st 2018.
（293）Okuda N, Okayama A, Miura K, et al. Food sources of dietary sodium in the Japanese
adult population: the international study of macro-/micronutrients and blood pressure(INTERMAP). European journal of nutrition 2017; 56 (3): 1269-80. doi: 10.1007/s00394-016-11771.
（294）堀田宗徳. 最近の中食の動向. 日本調理科学会誌 2007; 40 (2): 104-08.

第2章

保健指導の基礎知識

grants.cancer.gov/diet/usualintakes/pop/2001-04/. Accessed March 1, 2018.
（292）厚生省公衆衛生局栄養課. 国民栄養の現状（昭和22年国民栄養調査成績）1948 [Available from:（296）独立行政法人農畜産業振興機構. 平成28年度カット野菜・冷凍野菜・野菜惣菜に係る小売販売動向調査,
2017.
（297）Ikeda N, Okuda N, Tsubota-Utsugi M, et al. Association of Energy Intake With the Lack ofin-Person Review of Household Dietary Records: Analysis of Japan National Health andNutrition Surveys From 1997 to 2011. Journal of epidemiology / Japan Epidemiological
Association 2016; 26 (2): 84-91. doi: 10.2188/jea.JE20150048.

保健指導プログラムの
構成と実際

第3章

（295）村本信幸. 外食産業市場規模と外食比率. 日本調理科学会誌 1995; 28 (4): 290-96.

（298）厚生労 働 省. 介 護 予防マニュアル（ 改 訂 版 ）2012 [Available from: http://www.mhlw.go.jp/
topics/2009/05/tp0501-1.html] accessed March 2 2018.

第4章（300）Eng PM, Kawachi I, Fitzmaurice G, et al. Effects of marital transitions on changes in
dietary and other health behaviours in US male health professionals. Journal of
epidemiology and community health 2005; 59 (1): 56-62. doi: 10.1136/jech.2004.020073.
（301）Nowson C, O'Connell S. Protein Requirements and Recommendations for Older People: A
Review. Nutrients 2015; 7 (8): 6874-99. doi: 10.3390/nu7085311.

保健指導の技術（299）葛谷雅文. 総論. 静脈経腸栄養, 2007; 22 (4): 433-7.

（302）Koba ya shi S, Asa kura K, Suga H, et a l. Hig h protein inta ke is a ssocia ted wit h low
prevalence of frailty among old Japanese women: a multicenter cross-sectional study.
Nutrition journal 2013; 12: 164. doi: 10.1186/1475-2891-12-164.
（303）厚生労働省. 日本人の食事摂取基準2015年 2014 [Available from: http://www.mhlw.go.jp/stf/（305）P h y s i c a l A c t i v i t y G u i d e l i n e s A d v i s o r y C o m m i t t e e : P h y s i c a l A c t i v i t y G u i d e l i n e s
Advisory Committee Report. 2008. U. S. Department of Health and Human Services, 2008.

支援の場面

shingi/0000041824.html] accessed March 12 2018.
（304）厚生労働省健康局健康課＜http://www.mhlw.go.jp/＞：平成28年国民健康・栄養調査結果

第5章（306）日本動脈硬化学会編：動脈硬化性疾患予防ガイドライン2017年版. 日本動脈硬化学会, 2017.
（307）日本高血圧学会高血圧治療ガイドライン作成委員会編. 高血圧治療ガイドライン2019. 日本高血圧学会,
2019.

skeletal muscle. Am J Physiol Endocrinol Metab, 306: E1085-E1092, 2014.
（310）Kodama S, et al.: Effect of aerobic exercise training on serum levels of high-density

9-19



（309）Sasaki T, et al.: Role of AMPK and PPARγ1 in exercise-induced lipoprotein lipase in

生活習慣病予防の社会制度

worldwide: an analysis of burden of disease and life expectancy. Lancet, 380: 219-229, 2012.

第6章

医療保険者の保健事業（308）L e e I M , e t a l . : E f f e c t o f p h y s i c a l i n a c t i v i t y o n m a j o r n o n - c o m m u n i c a b l e d i s e a s e sHealth Education Manual

lipoprotein cholesterol: a meta-analysis. Arch Intern Med, 167: 999-1008, 2007.
（311）Kraus WE, et al.: Effects of the amount and intensity of exercise on plasma lipoproteins.
N Engl J Med, 347: 1483-1492,2002.
（312）WHO: Recommended levels of physical activity for adults aged 18-64 years. ＜http://www.
who.int/dietphysicalactivity/factsheet_adults/en/＞（313）Weiss CO: Frailty and chronic diseases in older adults. Clin Geriatr Med, 27: 39-52, 2011.
（314）Walston J, et al.: Research agenda for frailty in older adults: toward a better understandingof physiology and etiology: summary from the American Geriatrics Society National
Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc, 54:
991-1001, 2006.
（315）Binder EF, et al.: Effects of exercise training on frailty in community-dwelling older
adults: results of a randomized, controlled trial. J Am Geriatr Soc, 50: 1921-1928, 2002.
（316）Gitlin LN, et al.: A randomized trial of a multicomponent home intervention to reduce
functional difficulties in older adults. J Am Geriatr Soc, 54: 809-816, 2006.
（317）介護予防マニュアル改訂委員会：「第３章運動器の機能向上マニュアル」介護予防マニュアル改訂版，
p46-64，平成24年３月，三菱総合研究所人間・生活研究本部，東京．＜http://www.mhlw.go.jp/
topics/2009/05/dl/tp0501-1_1.pdf＞（318）Peterson MJ, et al.: Physical activity as a preventative factor for frailty: the health,aging, and body composition study. J Gerontol A Biol Sci Med Sci, 64: 61-68, 2009.
（319）WHO: Global Recommendations on Physical Activity for Health. 2010.＜http://whqlibdoc.
who.int/publications/2010/9789241599979_eng.pdf＞（320）I k e d a N , e t a l . : A d u l t m o r t a l i t y a t t r i b u t a b l e t o p r e v e n t a b l e r i s k f a c t o r s f o r n o n communicable diseases and injuries in Japan: a comparative risk assessment. PLoS Med,
9: e1001160, 2012.
（321）Sedentary Behavior Research Network: Standardized use of the terms“sedentary”and“sedentary behaviors”. Appl Physiol Nutr Metab, 37: 540-542, 2012.
（322）Bauman A, et al.: The descriptive epidemiology of sitting.A 20-country comparison using
the International Physical Activity Questionnaire (IPAQ). Am J Prev Med, 41: 228-235, 2011.
（323）Thorp A, et al.: Sedentary Behaviors and subsequent health outcomes: a systematic
review of longitudinal studies, 1996-2011. Am J Prev Med, 41: 207-215, 2011.
（324）van der Ploeg HP, et al.: Sitting time and all-cause mortality risk in 222,497 Austrarian
adults. Arch Intern Med, 172: 494-500, 2012.
（325）Honda T, et al.: Sedentary bout durations and metabolic syndrome among working
adults: a prospective cohort study. BMC Public Health, 16: 888, 2016.
（326）Dunstan DW, et al.: Too much sitting-a health hazard. Diabetes Res Clin Pract, 97: 368-376,
2012.
（327）Armstrong MEG, et al.: Frequent physical activity may not reduce vascular disease risk
as much as moderate activity. Circulation, 131: 721-729, 2015.
（328）Hirayama T. Non-smoking wives of heavy smokers have a higher risk of lung cancer: astudy from Japan. BMJ 1981; 282;17:183-185.
（329）Fischer F, Kraemer A. Meta-analysis of the association between second-hand smoke
exposure and ischaemic heart diseases, COPD and stroke. BMC Public Health 2015;
15:1202 DOI 10.1186/s12889-015-2489-4.
（330）外務省. 水銀に関する水俣条約. https://www.mofa.go.jp/mofaj/ila/et/page22_001867.html（331）日本高血圧学会高血圧治療ガイドライン作成委員会編. 高血圧治療ガイドライン2019. 日本高血圧学会,

9-202019.
（332）Mancia G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task
Force for the Management of Arterial Hypertension of the European Society of

生活習慣病の疫学

第1章

Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;
25: 1105-1187.
Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA.
2003; 289: 2560-2572.
（334）Pickering TG, et al. Recommendations for blood pressure measurement in humans andexperimental animals: Part 1: blood pressure measurement in humans: a statement for
pr o f ess io na l s f r o m t he S u bc o m m i t t ee o f Pr o f ess i o na l a nd P u bl ic Ed uca t i o n o f t heAmerican Heart Association Council on High Blood Pressure Research. Hypertension.
2005; 45: 142-161.
（335）O’Brien E, et al. European Society of Hypertension recommendations for conventional,（336）日本循環器学会. 24時間血圧計の使用（ABPM）基準に関するガイドライン（2010年改訂版）. http://www.j-circ.or.jp/guideline/pdf/JCS2010_shimada_h.pdf（337）Hozawa A, et al. Prognosis of isolated systolic and isolated diastolic hypertension asassessed by self-measurement of blood pressure at home: the Ohasama study. Arch
Intern Med. 2000; 160: 3301-3306.
（338）Imai Y, et al. Usefulness of home blood pressure measurements in assessing the effect第3章

保健指導プログラムの構成と実際

ambulatory and home blood pressure measurement. J Hypertens. 2003; 21: 821-848.

第2章

保健指導の基礎知識（333）Chobanian AV, et al. The Seventh Report of the Joint National Committee on Prevention,of treatment in a single-blind placebo-controlled open trial. J Hypertens. 2001; 19: 179185.
from nationwide web-based monitoring in Japan. BMJ Open 2018; 8: e017351.
（340）Ma ncia G, et a l. Ambulatory blood pressure is superior to clinic blood pressure inpredicting treatment-induced regression of lef t ventricular hypertrophy. SAMPLE
Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril
Evaluation. Circulation. 1997; 95: 1464-1470.

第4章

保健指導の技術（339）Iwahori T, Miura K, Obayashi K et al. Seasonal variation in home blood pressure: findings（341）Staessen JA, et al. Predicting cardiovascular risk using conventional vs ambulatory
blood pressure in older patients with systolic hypertension. Systolic Hypertension in
Europe Trial Investigators. JAMA. 1999; 282: 539-546.
（342）O'Brien E, Parati G, Stergiou G et al. European Society of Hypertension position paper

APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation,and Management of High Blood Pressure in Adults: A Report of the American College of

支援の場面

on ambulatory blood pressure monitoring. J Hypertens 2013; 31: 1731-68.
（343）Whelton PK, Carey RM, Aronow WS et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/

第5章

Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Hypertension 2018; 71: e13-e115.
（344）Asayama K, Ohkubo T, Yoshida S et al. Stroke risk and antihypertensive drug treatment



生活習慣病予防の社会制度

第6章

医療保険者の保健事業

in the general population: the Japan arteriosclerosis longitudinal study. J Hypertens
2009; 27: 357-64.
（345）S t a esse n JA, Th i js L, Oh k u bo T et a l. Th ir t y yea r s o f resea rc h o n d ia g n ost ic a ndtherapeutic thresholds for the self-measured blood pressure at home. Blood Press Monit
2008; 13: 352-65.

9-21

Health Education Manual（346）Niira nen TJ, Asa yama K, Thi js L et al. Outcome-driven thresholds f or home bloodpressure measurement: international database of home blood pressure in relation to
cardiovascular outcome. Hypertension 2013; 61: 27-34.
（347）E t t e h a d D , E m d i n C A , K i r a n A e t a l . B l o o d p r e s s u r e l o w e r i n g f o r p r e v e n t i o n o fcardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;
387: 957-967.
（348）INTERSALT Cooperative Research Group. INTERSALT: a n international study ofelec t r o l y t e exc ret io n a nd bl ood press u re. Res u l t s f or 24 h o u r u r i na r y sod i u m a nd
potassium excretion. Br Med J 1998; 297: 319-328.
（349）K u f t F C, F i n e be r g N S , S l oa n R S . E s t i ma t i n g d i e t a r y s od i u m i n t a k e i n i n d i v id u a l s
receiving a randomly fluctuating intake. Hypertension 1982; 4: 805-808.
（350）Yamasue K, Tochikubo O, Kono E, et al. Self-monitoring of home blood pressure withestimation of daily salt intake using a new electrical device. J Hum Hypertens 2006; 20:593-598.
（351）川崎晃一, 上園慶子, 伊藤和枝, 上野道雄, 藤島正敏. 尿中クレアチニン排泄量予測値と起床後２回目のス
ポット尿を用いた24時間尿中ナトリウムならびにカリウム排泄量の推定法．健康科学 1988; 10: 115-120.
（352）Tanaka T, Okamura T, Miura K, et al. A simple method to estimate populational 24-h
urinary sodium and potassium excretion using a casual urine specimen. J Hum
Hypertens 2002; 16: 97-103.
（353）Yoshita K, Miura K, Okayama A, et al. A validation study on food composition tables forthe international cooperative INTERMAP study in Japan. Environ Health Prev Med
2005; 10: 150-156.
（354）Anderson CA, Appel LJ, Okuda N et al. Dietary sources of sodium in China, Japan, theU n i t ed K i n g d o m, a n d t h e U n i t ed S t a t es, w o me n a n d m e n a g ed 40 t o 59 y ea r s: t h e
INTERMAP study. J Am Diet Assoc. 2010; 110: 736-745.
（355）S a s a k i S , Y a n a g i m o r i R , A m a n o K . V a l i d i t y o f a s e l f - a d m i n i s t e r e d d i e t h i s t o r yquestionnaire for assessment of sodium and potassium – Comparison with single 24-hoururinary excretion. Jpn Circ J 1998; 62: 431-435.
（356）K o b a y a s h i S , H o n d a S , M u r a k a m i K , e t a l . B o t h c o m p r e h e n s i v e a n d b r i e f s e l f administered diet history questionnaires satisfactorily rank nutrient intakes inJapanese adults. J Epidemiol 2012; 22: 151–159.
（357）日本高血圧学会減塩委員会. 日本高血圧学会減塩委員会報告2012. 日本高血圧学会; 2012.
（358）糖尿病診断基準に関する調査検討委員会：糖尿病の分類と診断基準に関する委員会報告（国際標準化対
応版）
糖尿病55
（7）
：485-504，2012.
（359）W o r l d H e a l t h O r g a n i z a t i o n : D e f i n i t i o n a n d D i a g n o s i s o f D i a b e t e s M e l l i t u s a n d
Intermediate Hyperglycemia. Report of a WHO/IDF consultation, 2006（http://www.
who.int/diabetes/publications/diagnosis_diabetes2006/en/）（360）日本糖尿病学会：熊本宣言2013（http://www.jds.or.jp/）（361）動脈硬化性疾患予防ガイドライン2012年版．日本動脈硬化学会, 2012.
（362）N a k a m u r a M, S a t o S , S h i m a m o t o T. I m pr o v e m e n t i n Ja pa n e s e c l i n i c a l l a b o r a t o r ymeasurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference
Method Laboratory Network. J Atheroscler Thromb. 10: 145-53. 2003.
（363）Miida T, Nishimura K, Okamura T, et al. A multicenter study on the precision andaccuracy of homogeneous assays for LDL-cholesterol: comparison with a betaqua ntif ication method using f resh serum obtained f rom non-diseased a nd diseased

9-22

subjects. Atherosclerosis. 225: 208-15. 2012.
（364）Miida T, et al. Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the
Postprandial and Fasting State. J Atheroscler Thromb. 2017; 24 (6): 583-599.

生活習慣病の疫学

第1章（365）Sug imoto K, Isobe K, Kawakami Y, Yamada N. The relationship between non-HDL
cholesterol and other lipid parameters in Japanese subjects. J Atheroscler Thromb. 12:

in Japan with non-HDL cholesterol as the second target. J Atheroscler Thromb. 15: 116-21.
2008.
（367）Kuwabara K, et al. Relationship between Non-High-Density Lipoprotein Cholesterol and
Low-Density Lipoprotein Cholesterol in the General Population. J Atheroscler Thromb.
2016; 23 (4): 477-90.
（368）N a k a m u r a M , K o y a m a I , I s o H , e t a l . M e a s u r e m e n t p e r f o r m a n c e o f r e a g e n t
manufacturers by Centers for Disease Control and Prevention/Cholesterol Reference
focused health checkups program in Japan. J Atheroscler Thromb. 16: 756-63. 2009.
（369）Iso H, Naito Y, Sato S, et al. Serum triglycerides and risk of coronary heart disease
among Japanese men and women. Am J Epidemiol. 153: 490-9. 2001.
（370）臨床検査のガイドラインJSLM2012．日本臨床検査医学会. 2012.
（371）日本痛風・核酸代謝学会ガイドライン改訂委員会：高尿酸血症・痛風の治療ガイドライン改訂第３版編集.
2019.

第3章

保健指導プログラムの構成と実際

Method Laboratory Network lipid standardization specified for metabolic syndrome-

第2章

保健指導の基礎知識

107-10. 2005.
（366）Shimano H, Arai H, Harada-Shiba M, et al. Proposed guidelines for hypertriglyceridemia（372）Kanabrocki EL, Third JL, Ryan MD, et al. Circadian relationship of serum uric acid andnitric oxide. JAMA. 283: 2240-1. 2000.
serum uric acid concentration. Am J Clin Nutr. 53: 665-9. 1991.
（374）Goldfarb DS1, MacDonald PA, Hunt B, Gunawardhana L. Febuxostat in gout: serum urate
response in uric acid overproducers and underexcretors. J Rheumatol. 2011; 38: 1385-9.
（375）Law MR, et al. Use of blood pressure lowering drugs in the prevention of cardiovasculardisease: meta-analysis of 147 randomised trials in the context of expectations f rom

第4章

保健指導の技術（373）Garrel DR, Verdy M, PetitClerc C, et al. Milk- and soy-protein ingestion: acute effect onprospective epidemiological studies. BMJ. 2009; 338: b1665.
（376）Tr u n bu l l F, et a l. Ef f ect s o f di f f eren t blood - pressure- lower i ng reg imen s o n ma jor
cardiova scular events: results of prospectively-desig ned overviews of ra ndomized
trials. Lancet. 2003; 362: 1527-1535.
quantitative overview updated until 1 March 2003. J Hypertens. 2003; 21: 1055-1076.
（378）日本高血圧学会高血圧治療ガイドライン作成委員会編. 高血圧治療ガイドライン2019. 日本高血圧学会,
2019.

支援の場面

（377）S t a e s s e n J A , e t a l . C a r d i o v a s c u l a r p r e v e n t i o n a n d b l o o d p r e s s u r e r e d u c t i o n : a

第5章（379）Miura K, Nagai M, Ohkubo T. Epidemiology of hypertension in Japan: where are wenow? Circ J 2013; 77: 2226-31.
（380）Mori H, Ukai H, Yamamoto H et al. Current status of antihypertensive prescription and脂質管理目標 日本動脈硬化学会（編）
p.49-57 2017年 東京.

9-23



meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009; 122: 290-300.
（382）動脈硬化性疾患予防ガイドライン2017年版 第４章包括的リスク管理１動脈硬化性疾患の絶対リスクと生活習慣病予防の社会制度（381）Wald DS, et al. Combination therapy versus monotherapy in reducing blood pressure:第6章

医療保険者の保健事業

associated blood pressure control in Japan. Hypertens Res 2006; 29: 143-51.

Health Education Manual（383）Nakamura H, Arakawa K, Itakura H, et al. for MEGA study group: Primary preventiono f ca rd i o va sc u la r d i sea se w i t h pra va st a t i n i n Ja pa n (MEGA st ud y ): a pr o s pec t i ve
randomized controlled trial. Lancet. 368: 1155-63, 2006.
（384）S c a n d i n a v i a n s i m v a s t a t i n s u r v i v a l s t u d y g r o u p : R a n d o m i z e d t r i a l o f c h o l e s t e r o llowering in 4444 patients with coronary heart disease; the Scandinavian simvastatin
survival study (4S). Lancet. 344: 1383-89, 1994.
（385）動脈硬化性疾患予防ガイドライン2017年版 第４章包括的リスク管理３薬物療法 日本動脈硬化学会（編）
p.81-96 2017年 東京.
（386）Ballantyne CM, Houri J, Notarbartolo A, et al.: the ezetimibe study group: Effect ofe z e t i m i b e c o a d m i n i s t e r e d w i t h a t o r v a s t a t i n i n 628 p a t i e n t s w i t h p r i m a r yhypercholesterolemia: a prospective, randomized, double-blind trial. Circulation, 107:2409-15, 2003.
（387）Kastelin JJ, Akdim F, Stroes ES, Zwinderman AH, et al. for the ENHANCE investigators:
Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med.
358:1431-43, 2008.
（388）Thomopoulos C, Ska lis G, Micha lopoulou H, et a l. Ef f ect of low-densit y lipoproteincholesterol lowering by ezetimibe/simvastatin on outcome incidence: overview, metaanalysis, and meta-regression analyses of randomized trials. Clin Cardiol 2015; 38: 763-769.
（389）Yokoyama M, Origasa H, Matsuzaki M, et al. for the Japan EPA lipid intervention study(JELIS) investigators: Ef fects of eicosapentaenoic acid on ma jor coronary events in
hypercholesterolaemic patients (JELIS): a randomized open-label, blinded endpoint
analysis. Lancet. 369; 1090-9, 2007.
（390）Ni YG, Condra JH, Orsatti L, et al. A proprotein convertase subtilisin-like / kexin type 9( P C S K9) C - t e r m i n a l d o m a i n a n t i b o d y a n t i g e n - b i n d i n g f r a g m e n t i n h i b i t s P C S K9internalization and restores low density lipoprotein up take. J Biol Chem 2010; 285: 1288212891.
（391）日本痛風・核酸代謝学会ガイドライン改訂委員会：高尿酸血症・痛風の治療ガイドライン改訂第３版編集.
2019.

9-24

（392）www.glycemicindex.com（393）Different trends in serum cholesterol levels among rural and urban populations aged
40-59 i n J a p a n f r o m 1960 t o 1990. O k a y a m a A , U e s h i m a H , M a r m o t M G , E l l i o t t P ,生活習慣病の疫学

第1章

Yamakawa M, Kita Y.J Clin Epidemiol. 1995 Mar; 48 (3): 329-37.
（394）E p i d e m i o l o g i c a l s t u d i e s i n t h e U p e r n a v i k d i s t r i c t , G r e e n l a n d . I n c i d e n c e o f s o m e

礎資料調査報告書」.
（396）T h e e f f e c t s o f d i f f e r e n t f o o d f a t s o n s e r u m c h o l e s t e r o l c o n c e n t r a t i o n i n m a n .
A N D E R S O N J T , K E Y S A , G R A N D E F . J N u t r . 1957 J u l 10; 62 (3) : 421-4. N o a b s t r a c t
available.
（397）Dietary protein sources and the risk of stroke in men and women. Bernstein AM1, Pan A,
Rexrode KM, Stampfer M, Hu FB, Mozaffarian D, Willett WC.
（398）Panel on Dietary Reference Intakes for Electrolytes and Water SCotSEoDRI. Dietary
The National Academies Press 2005.
（399）奥田奈賀子 岡山明. ナトリウム・カリウム摂取と循環器疾患. 循環器内科 2011; 70 (6): 546-54.
（400）WHO. Guideline: Sodium intake for adults and children 2012 [Available from: http://
www.who.int/nutrition/publications/guidelines/sodium_intake/en/index.html
accessed March 9 2018.]（401）厚生労働省. 日本人の食事摂取基準2015年 2014 [Available from: http://www.mhlw.go.jp/stf/

第3章

保健指導プログラムの構成と実際

Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. Washington, DC:

第2章

保健指導の基礎知識

chronic diseases 1950-1974. Kromann N, Green A. Acta Med Scand. 1980; 208 (5): 401-6.
（395）内閣府食品安全委員会. 平成18年度食品安全確保総合調査：「食品に含まれるトランス脂肪酸の評価基

shingi/0000041824.html accessed March 12 2018.]（402）日 本 高 血 圧 学 会. 高 血 圧 治 療 ガ イド ラ イ ン 2014 [Available from: https://www.jpnsh.jp/（403）厚生労働省. 平成28年国民健康・栄養調査報告 2017 [Available from: http://www.mhlw.go.jp/
bunya/kenkou/eiyou/h28-houkoku.html accessed March 9 2018.]（404）K r a u s s R M, Ec k e l R H, H o wa r d B, e t a l . AHA Di e t a r y G u i d e l i n e s: r e v i s i o n 2000: A
statement for healthcare professionals from the Nutrition Committee of the American
Heart Association. Circulation 2000; 102 (18): 2284-99. [published Online First: 2000/11/01]

第4章

保健指導の技術

guideline.html accessed March 13 2015.]（405）Young DB, Lin H, McCabe RD. Potassium's cardiovascular protective mechanisms. The
A m e r i c a n jo u r n a l o f p h y s i o l o g y 1995; 268 (4 P t 2): R825-37. [ p u b l i s h ed On l i n e F i r s t :1995/04/01]（406）He FJ, MacGregor GA. Beneficial effects of potassium on human health. Physiologia

bunya/kenkou/eiyou/h28-houkoku.html accessed March 9 2018.]（408）Panel on Dietary Reference Intakes for Electrolytes and Water SCotSEoDRI. Dietary

支援の場面

plantarum 2008; 133 (4): 725-35. [published Online First: 2008/08/30]（407）厚生労働省. 平成28年国民健康・栄養調査報告 2017 [Available from: http://www.mhlw.go.jp/

第5章

Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. Washington, DC:
The National Academies Press 2005.
（409）日本腎臓学会. 慢性腎臓病に対する食事療法基準2014年版. 東京: 東京医学社 2014.

shingi/0000041824.html accessed April 9 2016.]

9-25



July 31th 2013.]（411）厚生労働省. 日本人の食事摂取基準2015年 2014 [Available from: http://www.mhlw.go.jp/stf/

生活習慣病予防の社会制度

www.who.int/mediacentre/news/notes/2013/salt _ potassium_20130131/en/ accessed

第6章

医療保険者の保健事業（410）WHO. Guideline: Potassium intake for adults and children 2012 [Available from: http://

Health Education Manual（412）文部科学省科学技術・学術審議会資源調査分科会. 日本食品標準成分表2015年版（七訂）. 東京: 全国官報
販売協同組合 2015.
（413）Okuda N, Okayama A, Miura K, et al. Food sources of dietary sodium in the Japanese
adult population: the international study of macro-/micronutrients and blood pressure(INTERMAP). European journal of nutrition 2017; 56 (3): 1269-80. doi: 10.1007/s00394-016-11771.
（414）厚生労働省. 日本人の食事摂取基準2015年 2014 [Available from: http://www.mhlw.go.jp/stf/
shingi/0000041824.html accessed March 12 2018.]（415）WHO. Guideline: Potassium intake for adults and children 2012 [Available from: http://
www.who.int/nutrition/publications/guidelines/potassium_intake/en/accessed]（416）日本病院薬剤師会雑誌, 第40巻8号, P951-953, 2004.
（417）Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene
and Retinol Efficacy Trial. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen
MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, Barnhart S,
Cherniack MG, Brodkin CA, Hammar S.J Natl Cancer Inst. 1996 Nov 6; 88 (21): 1550-9.
（418）Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ,
V o l l m e r WM, L i n PH, S v e t k e y L P, S t ed ma n S W, Y o u n g DR ; W r i t i n g G r o u p o f t h e
PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification
on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003; 289:
2083-93.
（419）板井一好, 奥田奈賀子, 岡山明. 岩手県内における主な外食に含まれる食塩量について. 第52回日本循環器病予防学会学術集会; 2016 2016年６月; さいたま市.
（420）Okuda N, Okayama A, Miura K, et al. Food sources of dietary sodium in the Japanese
adult population: the international study of macro-/micronutrients and blood pressure(INTERMAP). European journal of nutrition 2017; 56 (3): 1269-80. doi: 10.1007/s00394-016-11771.
（421）適塩・血圧対策推進協会. ナト・カリ塩とは [Available from: http://www.lowsalt.or.jp/natokari.
html accessed January 12 2018.]（422）日本体力医学会体力科学編集委員会・監訳：「１．身体活動に伴う有益性とリスク」，運動処方の指針−
運動負荷試験と運動プログラム−，原書第８版，p8-9，2011，南江堂，東京．
（423）石井直方：スロートレーニング（特集 常識を打ち破る運動生理学の新知見）．体育の科学，59（3），177183，2009．
（424）河村顕治：「24変形膝関節症」，運動療法ガイド−正しい運動処方を求めて，井上一，武藤芳照，福田潤編著，改訂第4版，p348-356，2006，南江堂，東京．
（425）Hambrecht RP, Schuler GC, Muth T: Greater diagnostic sensitivity of treadmill versus
cycle exercise testing of asymptomatic men with coronary artery disease. Am J Cardiol,70: 141-146, 1992.
（426）Myers J, Bucha na n N, Wa lsh D: Comparison of t he ramp versus sta ndard exercise
protocols. J Am Coll Cardiol, 17: 1334-1342, 1991.
（427）Gellish RL, Goslin BR, Olson RE, McDonald A, Russi GD, Moudgil VK: Longitudinalmodeling of the relationship between age and maximal heart rate. Med Sci Sport Exer,
39: 822-829, 2007.
（428）村瀬訓生，勝村俊仁，上田千穂子，井上茂，下光輝一：身体活動量の国際標準化―IPAQ日本語版の信頼性，妥当性の評価―，厚生の指標，49（11）：1-9，2002．
（429）Craig C.L., Marshall A.L., Sjöström M., Bauman A.E., Booth M.L., Anisworth B.E., et al.

9-26

International physical activity questionnaire: 12-country erliability and validity. Med Sci
Sports Exerc. 35, 1381-1395. 2003.
（430）池上晴夫：運動処方−理論と実際−，新版，p147，1990，朝倉書店，東京．

生活習慣病の疫学

第1章（431）運動基準・運動指針の改定に関する検討会：「健康づくりのための身体活動基準2013」，運動基準・運動指針の改定に関する検討会報告書，2013.＜http://www.mhlw.go.jp/stf/houdou/2r9852000002

05-Shingikai-10901000-Kenkoukyoku-＞（433）Ishikawa-Takata K, Tabata I, Sasaki S, et al. Physical activity level in healthy free-living
Japanese estimated by doubly labelled water method and International Physical
Activity Questionnaire. Eur J Clin Nutr, 62:885-891, 2008.
（434）Ishikawa-Takata K, Naito Y, Tanaka S, et al. Use of doubly labeled water to validate aphysical activity questionnaire developed for the Japanese population. J Epidemiol, 21:
114-121, 2011.
with resistance exercise training：a systematic review of current evidence. Angiology,
60: 614-632, 2009.
（436）M i y a c h i M , e t a l . : U n f a v o r a b l e e f f e c t s o f r e s i s t a n c e t r a i n i n g o n c e n t r a l a r t e r i a lcompliance: a randomized intervention study. Circulation, 110: 2858-2863, 2004.
（437）Okamoto T, et al.: Effects of eccentric and concentric resistance training on arterial
stiffness. J Hum Hypertens, 20: 348-354, 2006.

第3章

保健指導プログラムの構成と実際（435）Tambalis K, et al.: Responses of blood lipids to aerobic, resistance, and combined aerobic

第2章

保健指導の基礎知識

xple-att/2r9852000002xpqt.pdf＞（432）厚生労働省：「日本人の食事摂取基準（2015年版）」
策定検討会報告書．＜http://www.mhlw.go.jp/file/（438）Yamamoto K, et al.: Poor trunk flexibility is associated with arterial stiffening. Am J
Physiol Heart Circ Physiol, 297: H1314-H1318, 2009.
学，22（臨時増刊号）：150-157，2005．
（440）栁田昌彦，交野好子：福井県における楽しい集団的介護予防体操「ふくいイッチョライダンベル体操」の創作．北陸公衆衛生学会誌，33（2）：60-69．2007．
（441）栁田昌彦，塩津陽子，炭本佑佳：５年間にわたる「ふくいイッチョライダンベル体操」の定期的実践が地
域在住高齢女性の生活体力，形態および健康関連QOLに及ぼす効果―福井県敦賀市の介護予防地域支第4章

保健指導の技術（439）野村武雄，金田晃一：ⅰ．アクアエクササイズ，高齢社会における運動支援実践ガイド．臨床スポーツ医

援事業に介入して―．ライフケアジャーナル，７（1）：7-14，2016.
（442）Br Med J. 1964 Jun 6; 1 (5396): 1460-7 MORTALITY IN RELATION TO SMOKING: TENYEARS' OBSERVATIONS OF BRITISH DOCTORS. DOLL R, HILL AB.
Ⓡ（443）生活習慣病予防研究センター. 簡易版食傾向調査票, 生活調査票「知食スマート版 」2019 [Available

Japan. J Atheroscler Thromb (accepted on Dec 11, 2017) 2017.
（445）Prochaska JO, et al. The transtheoretical model of health behavior change. Am J Health

支援の場面

from: http://www.jrisp.com/shg/accessed August 30 2019.]（444）Okuda N, Itai K, Okayama A. Usefulness of a short dietary propensity questionnaire in

第5章

Promot 1997; 38-48.
（446）Prochaska JO, et al.“The transtheoretical model and stages of change”, Health behavior
and health education: theory. research, and practiee. 4th ed. Glang K, et al. eds. Jossey-

扱うに当たっての留意事項について．

9-27



実践的プログラム. 2007; 175.
（448）個情第752号，基発0529第６号平成29年５月29日 雇用管理分野における個人情報のうち健康情報を取り

生活習慣病予防の社会制度（447）岡山明編著, 保健同人社. 生活習慣改善シリーズ メタボリックシンドローム予防の健康教育教材を用いた

第6章

医療保険者の保健事業

Bass 2008; 97-121.